Prof. Salem Chouaib is a research director and is heading a research unit devoted to cancer immunology and immunotherapy. In 1986, he was appointed as a research associate at the French National Institute of Health and Biomedical Research (INSERM) and joined the tumor biology laboratory at the Institut Gustave Roussy. He completed his undergraduate studies in biochemistry at the University of Pierre and Marie
Curie (Paris VI) and immunology at the Pasteur Institute. In 1983, he received his Doctorate in immunology from the same university. He then joined the Memorial Sloan Kettering Cancer Center in New York where he undertook post-doctoral training in the laboratory of Human Immunogenetics Laboratory. He was awarded the cancer research prize of the French Ligue Against Cancer in 1992 and, in 2004, the presidential prize in biotechnology. His laboratory currently focuses on the investigation of the functional cross-talk between cytotoxic cells and tumor targets in the context of tumor microenvironment complexity and plasticity. His research is constantly directed at impulsing the transfer of fundamental concepts in clinical applications, in particular in the field of cancer vaccines and cancer immunotherapy.
